IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Pharma/fine chemicals roundup—24 December 2013

2:15 AM MST | December 24, 2013 | Deepti Ramesh

Perrigo completes acquisition of Elan for $8.6 billion Health-care products firm Perrigo (Allegan, MI) says that it has completed the previously announced acquisition of biotechnology company Elan (Dublin), for about $8.6 billion. Perrigo and Elan have been combined under a new company incorporated in Ireland and have adopted the global name Perrigo Co. plc. Shares of Perrigo will trade on the New York Stock Exchange and the Tel Aviv Stock Exchange. Perrigo develops, manufactures, and distributes OTC and generic prescription pharmaceuticals, nutritional products...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa